article thumbnail

Clinical Trial Data Provides “Compelling Evidence” That Vaporized Cannabis Mitigates Migraine Symptoms

NORML

These data further affirm patients' testimonials." The post Clinical Trial Data Provides “Compelling Evidence” That Vaporized Cannabis Mitigates Migraine Symptoms appeared first on NORML.

article thumbnail

Cannabis Business Data Security Precautions

MaxQ Cannabis

Cannabis businesses share the modern environment of extremely high data security risk. The cannabis industry occupies a unique spot when it comes to user data security.

Data 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Making Sense of Cannabis Dosing

Americans for Safe Access

For example, data from the National Institute on Drug Abuse reveal that the level of THC in cannabis samples seized by law enforcement averaged 4% in 1995. By now, it is a common refrain: the weed is getting stronger. Recent research backs this up. By contrast, in 2022, the average level of THC was upwards of 16%.

Data 256
article thumbnail

Cannabis Report FY2024 (IDOA portion)

Illinois News Joint

The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Continue to build on progress tracking and developing data. Continue to streamline licensing and inspections processes with paperless data. Begin implementation of updated USDA Hemp Rules.

article thumbnail

Cannabis Report FY2024 (IDPH portion)

Illinois News Joint

The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. Refresh QA plans with a focus on staffing assignments.

article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Ultimately, they concluded that the available data on pain and other outcomes was unreliable, with a high risk of bias. On postoperative days 0, 1, 2, 7, 14, and 42, researchers with Thomas Jefferson University in Philadelphia collected data on patient pain, sleep, and opioid use. A killer app for pain?

Topical 176
article thumbnail

What Cannabis Manufacturers Can Learn from End-User Data Analytics

MaxQ Cannabis

Data analytics is a vital tool for any business or industry, and the Cannabis industry is no exception. Many Businesses Intelligence (BI) tools are available to Cannabis […] The post What Cannabis Manufacturers Can Learn from End-User Data Analytics appeared first on MaxQ Technologies.

Data 59